Study of Individualized Amonafide to Treat Prostate Cancer
NCT00087854
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Amonafide L-malate (drug)
Sponsor
Xanthus Pharmaceuticals, Inc.